Les lots de vaccins anti-COVID-19 à apparente faible toxicité : pas des placebos, mais retards de publication des rapports VAERS d'effets indésirables

2026 Open access

Read full text

Authors: Albert Benavides, Gary Hawkins, Hervé Seligmann

DOI: 10.13140/rg.2.2.33700.54400

Cited by: 0

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research Vaccine Coverage and Hesitancy Heparin-Induced Thrombocytopenia and Thrombosis